Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen Corporation

News   Aug 16, 2014

 
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen Corporation
 
 
 

RELATED ARTICLES

Insulin Goes Viral: Diabetes and Cancer-causing Mechanisms Explored

News

Every cell in your body responds to the hormone insulin, and if that process starts to fail, you get diabetes. In an unexpected finding, scientists have identified four viruses that can produce insulin-like hormones that are active on human cells. The discovery brings new possibilities for revealing biological mechanisms that may cause diabetes or cancer.

READ MORE

Psoriasis Drug Also Reduces Aortic Inflammation

News

An antibody used to treat the autoimmune skin disease psoriasis is also effective at reducing aortic inflammation, a key marker of future risk of major cardiovascular events.

READ MORE

Stem-Cell Exosome Treatment Repairs Brain Damage Following Stroke

News

A team of researchers have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE